Lorrain Daniel S.
Chief Scientific Officer
CIK 0001861550 · 1 filing · 1 company · last filed Jul 2, 2026
Filing tape
Filed Thu, Jul 2, 2026
- −4,170 sh · $561.2K
- Exercised28,826Class A Common Stock@ $1.01→ 168,198 held
- Sold28,826Class A Common Stock@ $16.04→ 139,372 held
- Exercised4,183Class A Common Stock@ $1.01→ 143,555 held
- Sold5,852Class A Common Stock@ $15.67→ 137,703 held
- Sold2,501Class A Common Stock@ $16.24→ 135,202 held
- Exercised28,826Stock Option (right to buy)→ 38,480 held
- Exercised4,183Stock Option (right to buy)→ 34,297 held
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.